Clinical trial
Radiation Therapy and Combination Chemotherapy in Treating Young Patients With…
NCT00276666 · Children's Cancer and Leukaemia Group, Other · Unknown status
Key facts
| NCT number | NCT00276666 |
|---|---|
| Title | Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery |
| Official title | Hyperfractionated Accelerated Radiotherapy (HART) With Chemotherapy (Cisplatin, CCNU, Vincristine) for Metastatic (M1-3) Medulloblastoma |
| Lead sponsor | Children's Cancer and Leukaemia Group, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cisplatin, lomustine, vincristine sulfate, adjuvant therapy, radiation therapy |
| Enrollment | 29 |
| Start date | Nov 1, 2001 |
| Primary completion | Mar 1, 2010 |
| First posted | Jan 13, 2006 |
| Last update posted | Sep 17, 2013 |
| Countries | Ireland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: